140 related articles for article (PubMed ID: 37322388)
1. The added value of (1,3)-β-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
Christner M; Abdennadher B; Wichmann D; Kluge S; Pepić A; Aepfelbacher M; Rohde H; Olearo F
Infection; 2024 Feb; 52(1):73-81. PubMed ID: 37322388
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis.
Kritikos A; Poissy J; Croxatto A; Bochud PY; Pagani JL; Lamoth F
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32238435
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
Kritikos A; Caruana G; Poissy J; Mamin A; Bachmann D; Pagani JL; Coste AT; Lamoth F
J Clin Microbiol; 2023 Feb; 61(2):e0169122. PubMed ID: 36700626
[TBL] [Abstract][Full Text] [Related]
5. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
White SK; Schmidt RL; Walker BS; Hanson KE
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
[TBL] [Abstract][Full Text] [Related]
6. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD
PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929
[TBL] [Abstract][Full Text] [Related]
7. Lower beta-1,3-D-glucan testing cut-offs increase sensitivity for non-albicans Candida species bloodstream infections.
Forster J; Dichtl K; Wagener J
Mycoses; 2022 May; 65(5):500-507. PubMed ID: 35020235
[TBL] [Abstract][Full Text] [Related]
8. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of β-D-glucan alone or combined with Candida score, colonization index and C-reactive protein for candidemia.
Kazancioglu S; Bastug A; Kayaaslan B; Mutlu NM; Calci E; Turhan T; Mumcuoglu I; Akinci E; Bodur H
J Infect Dev Ctries; 2022 Feb; 16(2):362-368. PubMed ID: 35298433
[TBL] [Abstract][Full Text] [Related]
10. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
[TBL] [Abstract][Full Text] [Related]
11. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
[TBL] [Abstract][Full Text] [Related]
12. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
[TBL] [Abstract][Full Text] [Related]
14. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
[TBL] [Abstract][Full Text] [Related]
15. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
[TBL] [Abstract][Full Text] [Related]
16. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Risk Score for Predicting Invasive Candidiasis in Intensive Care Unit Patients by Incorporating Clinical Risk Factors and Lymphocyte Subtyping.
Zhang J; Cheng W; Li D; Chen J; Zhao G; Wang H; Cui N
Front Cell Infect Microbiol; 2022; 12():829066. PubMed ID: 35573797
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis.
Guo J; Wu Y; Lai W; Lu W; Mu X
BMC Infect Dis; 2019 Aug; 19(1):716. PubMed ID: 31412796
[TBL] [Abstract][Full Text] [Related]
19. Serial (1-3)-beta-D-Glucan (BDG) monitoring shows high variability among premature neonates.
Ferreras-Antolin L; Aziz N; Warris A
Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35561703
[TBL] [Abstract][Full Text] [Related]
20. Clinical Sensitivity of the (1-3)-β-D-glucan Test for Predicting Candidemia.
Lee YW; Lim SY; Jin S; Park HJ; Sung H; Kim MN; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Chong YP
Ann Lab Med; 2023 Jul; 43(4):381-385. PubMed ID: 36843407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
